Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Atara Biotherapeutics, Inc.

NASDAQ: ATRAHealthcare / Biotechnology / USA
38.17-1.21-3.07%Vol 259 5071Y Perf -12.14%
Feb 21st, 2019 16:00
BID36.51 ASK39.85
Open39.28 Previous Close39.38
Pre-Market- After-Trading38.17
 - -%  - -%
Target Price
47.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
24.44 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-99 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-99 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-99 
Income Ranking
 —    -
Market Cap (mil)1 742 
Earnings Rating
Sell
Price Range Ratio 52wk %
38.80 
Earnings Date
26th Feb 2019

Today's Price Range

37.6639.28

 

52wk Range

27.8554.45

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
7.70%
3 Months
-0.50%
6 Months
0.53%
1 Year
-12.14%
3 Years
132.89%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ATRA38.17-1.2100-3.07
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
13.50
Current Ratio
13.80
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.45
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-11.60
Cash Flow Per Share
-3.68
Price to Tangible Book
4.45
Book Value per Share
8.83
Enterprise Value (in ths.)
1 428 060
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-37.71
ROE last 12 Months
-61.29
Return on Assets (5Y Avg)
-17.82
ROA last 12 Months
-55.50
Return on Capital (5Y Avg)
-45.39
ROC last 12 Months
-61.08
Return on invested Capital Q
-13.64
Return on invested Capital Y
-55.37
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.18-1.29-9.32
Q02 2018-0.97-1.15-18.56
Q01 2018-0.93-1.05-12.90
Q04 2017-1.15-1.150.00
Q03 2017-1.03-1.020.97
Q02 2017-0.91-0.94-3.30
Q01 2017-0.77-0.88-14.29
Q04 2016-0.91-0.6330.77
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.310.00-
12/2018 FY-4.820.00-
3/2019 QR-1.350.00-
12/2019 FY-5.500.00-
Next Report Date26th Feb 2019
Estimated EPS Next Report-1.31
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume259 507
Shares Outstanding (in ths.)45 648
Trades Count1 480
Dollar Volume8 147 316
Avg. Volume478 013
Avg. Weekly Volume227 351
Avg. Monthly Volume304 143
Avg. Quarterly Volume492 409

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

78%22%

Bearish Bullish

68%32%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (62.50 %)
4 (57.14 %)
4 (57.14 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (25.00 %)
2 (28.57 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (12.50 %)
1 (14.29 %)
1 (14.29 %)
RatingModerate Buy
2.00
Moderate Buy
2.14
Moderate Buy
2.14

There are no comments yet.

News